Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$200.61 USD
-1.07 (-0.53%)
Updated Dec 4, 2023 04:00 PM ET
After-Market: $200.64 +0.03 (0.01%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum D VGM
Industry / Sector Report
Industry : Medical Services
Zacks Industry Rank
Top 32% (81 out of 251)Zacks Sector Rank
Top 13% (2 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.62 | 1.51 | 9.99 |
Current Quarter Estimate | 2.42 | 1.48 | 58.00 |
Year Ago Quarter Estimate | 2.98 | 0.51 | 50.35 |
Next Quarter Estimate | 2.41 | 1.51 | 59.00 |
Next Year Estimate | 10.98 | 8.09 | 250.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -5.04 | 5.70 | 14.24 |
Next Year | 3.98 | 19.20 | 11.11 |
Last 5 Years | 15.90 | 12.80 | 9.00 |
Next 5 Years | 8.90 | 15.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 18.06 | 17.34 |
Price/Book (MRQ) | 3.12 | 1.61 |
Price/Cash Flow (MRFY) | 11.76 | 8.62 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 11.27% | -8.95% |
Return on Equity (TTM) | 18.15% | -13.20% |
Debt to Equity (MRQ) | 0.76 | 29.06 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.